Skip to main content
ArticleOPEN ACCESS

The Growing Case for Use of SGLT2i in Heart Failure: Additional Benefits of Empagliflozin in a HFpEF Rodent Model

JACC: Basic to Translational Science
DOI: 10.1016/j.jacbts.2019.01.003
4Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

This article is free to access.

Author supplied keywords

Cite

CITATION STYLE

APA

Ha, C. M., & Wende, A. R. (2019, February 1). The Growing Case for Use of SGLT2i in Heart Failure: Additional Benefits of Empagliflozin in a HFpEF Rodent Model. JACC: Basic to Translational Science. Elsevier Inc. https://doi.org/10.1016/j.jacbts.2019.01.003

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free